At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EVFM Evofem Biosciences, Inc.
Trading 11-22 13:00:00 EST Delay
North American Morning Briefing: Russia's Nuclear Doctrine News Triggers Risk-Aversion
Dow Jones  ·  11-19
North American Morning Briefing: Russia's Nuclear Doctrine News Triggers Risk-Aversion
Evofem Biosciences Q3 Income From Operations USD -2.44 Million
THOMSON REUTERS  ·  11-15
Evofem Biosciences Q3 Income From Operations USD -2.44 Million
Press Release: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Dow Jones  ·  11-15
Press Release: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Aditxt Provides Update on Equity Line of Credit, Atm Usage, and Outstanding Number of Shares
THOMSON REUTERS  ·  11-08
Aditxt Provides Update on Equity Line of Credit, Atm Usage, and Outstanding Number of Shares
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Business Wire  ·  11-08
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Aditxt announces Evofem secures voting agreements with investors for merger
TIPRANKS  ·  11-06
Aditxt announces Evofem secures voting agreements with investors for merger
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger With Aditxt's Subsidiary Adifem
THOMSON REUTERS  ·  11-06
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger With Aditxt's Subsidiary Adifem
Press Release: Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
Dow Jones  ·  11-06
Press Release: Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
BRIEF-Evofem Secures Investor Support For Proposed Merger Through Voting Agreements
Reuters  ·  11-06
BRIEF-Evofem Secures Investor Support For Proposed Merger Through Voting Agreements
Press Release: Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Dow Jones  ·  11-06
Press Release: Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Evofem Secures Investor Support for Proposed Merger Through Voting Agreements
THOMSON REUTERS  ·  11-06
Evofem Secures Investor Support for Proposed Merger Through Voting Agreements
Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
Business Wire  ·  10-31
Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership With Broader Perspectives
THOMSON REUTERS  ·  10-29
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership With Broader Perspectives
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
Business Wire  ·  10-29
Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
Business Wire  ·  10-28
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
Press Release: Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time
Dow Jones  ·  10-21
Press Release: Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time
Press Release: Aditxt's Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili's Shareholder Approval
Dow Jones  ·  10-10
Press Release: Aditxt's Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili's Shareholder Approval
Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time
Business Wire  ·  10-09
Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
THOMSON REUTERS  ·  10-08
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
Business Wire  ·  10-08
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem

Introduction

Company Name.
Evofem Biosciences, Inc.
Affiliated Markets:
OTCQB
Listing Date:
--
Main Business:
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Issue price:
--